Humana Inc (NYSE: HUM)

Sector: Healthcare Industry: Healthcare Plans CIK: 0000049071
Market Cap 25.29 Bn
P/B 2.33
P/E 14.38
P/S 0.43
ROIC (Qtr) 16.98
Div Yield % 1.59
Rev 1y % (Qtr) 11.06
Total Debt (Qtr) 12.92 Bn
Debt/Equity (Qtr) 0.70
Add ratio to table...

About

Humana Inc., commonly known as Humana, is a company that operates in the healthcare and insurance industry. Its headquarters are located in Louisville, Kentucky, and its ticker symbol is HUM. The company's main business activities include providing health insurance services and healthcare services through its CenterWell segment. Humana generates revenue primarily through its insurance products, including Medicare Advantage, commercial fully-insured medical and specialty health insurance benefits, and administrative services only (ASO) contracts....

Read more

Investment thesis

Bull case

  • Healthy cash reserves of 5.39B provide 17.49x coverage of short-term debt 308M, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 40.10B provides 3.10x coverage of total debt 12.91B, indicating robust asset backing and low credit risk.
  • Tangible assets of 40.10B provide exceptional 151.32x coverage of deferred revenue 265M, showing strong service capability backing.
  • Robust free cash flow of 1.55B exceeds capital expenditure of 491M by 3.16x, indicating strong organic growth funding capability.
  • Operating cash flow of 2.04B provides exceptional 409x coverage of minority interest expenses 5M, showing strong core operations.

Bear case

  • Operating cash flow of 2.04B provides thin coverage of dividend payments of (429M) with a -4.77 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Short-term investments of 16.74B significantly exceed cash reserves of 5.39B, which is 3.11x, indicating potentially excessive yield-seeking behavior at the expense of liquidity.
  • Operating earnings of 2.22B show weak coverage of depreciation charges of 870M, with a 2.56 ratio indicating high capital intensity and potential reinvestment needs.
  • Free cash flow of 1.55B represents just -3.71x of debt issuance (419M), suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • High depreciation of 870M relative to operating cash flow of 2.04B, which is 0.43x suggests significant maintenance capital requirements affecting free cash flow.

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer comparison

Companies in the Healthcare Plans
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 UNH Unitedhealth Group Inc 275.49 Bn 47.39 1.75 80.14 Bn
2 CVS CVS HEALTH Corp 101.72 Bn 15.33 0.40 79.95 Bn
3 CI Cigna Group 85.42 Bn 23.60 0.41 34.04 Bn
4 ELV Elevance Health, Inc. 77.22 Bn 13.64 0.39 32.05 Bn
5 HUM Humana Inc 25.29 Bn 14.38 0.43 12.92 Bn
6 CNC Centene Corp 20.34 Bn -3.05 0.10 17.40 Bn
7 MOH Molina Healthcare, Inc. 7.17 Bn 15.19 0.16 3.95 Bn
8 ALHC Alignment Healthcare, Inc. 3.90 Bn -187.18 1.07 0.33 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.59 1.08
EV to Cash from Ops. EV/CFO -47.30 3.83
EV to Debt EV to Debt 2.26 9.18
EV to EBIT EV/EBIT 12.46 -1,594.13
EV to EBITDA EV/EBITDA 7.85 15.88
EV to Free Cash Flow [EV/FCF] EV/FCF -23.65 8.41
EV to Market Cap EV to Market Cap 1.15 1.08
EV to Revenue EV/Rev 0.50 0.68
Price to Book Value [P/B] P/B 2.33 4.79
Price to Earnings [P/E] P/E 14.38 -5.08
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 3.01 1.21
Dividend Payout Ratio % Div Payout % (Qtr) 33.10 29.17
Dividend per Basic Share Div per Share (Qtr) 3.54 2.51
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 27.40 16.79
Interest Coverage Int. cover (Qtr) 3.43 -0.47
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 0.61 -30.05
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 5.32 18.06
Dividend Growth (1y) % Div 1y % (Qtr) 0.00 2.04
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 0.45 -108.29
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 3.12 -60.87
EBIT Growth (1y) % EBIT 1y % (Qtr) -12.99 -84.20
EBT Growth (1y) % EBT 1y % (Qtr) -17.72 -142.02
EPS Growth (1y) % EPS 1y % (Qtr) -6.71 -164.11
FCF Growth (1y) % FCF 1y % (Qtr) 137.59 111.09
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 11.48 7.06
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 2.54 2.20
Cash Payout Ratio Cash Payout (Qtr) 0.17 0.11
Cash Ratio Cash Ratio (Qtr) 0.33 0.48
Current Ratio Curr Ratio (Qtr) 2.02 1.46
Debt to Equity Ratio Debt/Equity (Qtr) 0.70 0.77
Interest Cover Ratio Int Coverage (Qtr) 3.43 -0.47
Times Interest Earned Times Interest Earned (Qtr) 3.43 -0.47
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 2.40 1.97
EBIT Margin % EBIT Margin % (Qtr) 1.76 1.42
EBT Margin % EBT Margin % (Qtr) 1.25 0.98
Gross Margin % Gross Margin % (Qtr) 14.90 14.54
Net Profit Margin % Net Margin % (Qtr) 1.00 0.45